NICB International Conference on Global mRNA and Protein Expression Analysis
- Friday 8 September 2006

DCU’s National Institute for Cellular Biotechnology hosted a two-day International Conference on the use of new global approaches to understanding and eventually treating diseases such as breast cancer, prostate cancer and brain cancer. World-renowned experts addressed the conference, including representatives from science, industry and medicine. This integrated approach is fundamental to the development of cancer research.

Interesting talks include:

• Growth factor receptors as cancer therapeutic targets- John Crowne, Dublin
• EGFR and HER-2 antagonists in breast cancer therapy- Norma O’ Donovan, Dublin
• New approaches to treatment of brain cancer- Rolf Bjerkvig, Bergen
• Clinical Applications of expression profiling and proteomics in prostate cancer- John Masters, London
• Proteomic analysis of 5- Fluorouracil’s anti- proliferative effect on normal and cancer epithelial cells of the lung- William Bryan, DCU
• Ethical issues in biotechnology- Donal O’ Mathuna, Dublin
• Detection an molecular profiling of circulating tumour cells- Winifred Albert, Lagenhagen
• Advances in treatment of opportunistic fungal infections in cancer patients- Kevin Kavanagh, Maynooth
• Inhibiting efflux pumps that mediate cancer drug resistance – pharmacology and pharmacokinetics- Robert O’ Connor, DCU
• Repair of ocular damage- the need for stem cell therapy- William Power/ Andra Bobart, Dublin

ENDS